TrialBritish journal of clinical pharmacology2018

Safety, tolerability and pharmacokinetics/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first-in-human study and during experimental human endotoxaemia in healthy subjects.

Christopher Geven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.